Abstract
Dupilumab Effective in 6–11-Year-Olds With Moderate-to-Severe Asthma
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have